{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T22:15:30Z","timestamp":1783376130812,"version":"3.54.6"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"28","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013874","name":"ARTP","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013874","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,7,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Worldwide, prostate cancer (PCa) ranks second in terms of incidence and eighth in terms of mortality. While most cancers remain silent after initial treatment, some tumors recur. At present, we are unable to predict which patients are at risk of recurrence. In order to determine this risk of recurrence as early as at the biopsy stage, and to enable better therapeutic management of patients, it is essential to identify new biomarkers. In this study, we have demonstrated that Cysteine Dioxygenase CDO1 could be a predictive marker in PCa progression. Transcriptomic analysis showed that CDO1 expression is significantly reduced in patients who have relapsed and lower CDO1 expression is associated with poorer survival outcomes. In PCa, CDO1 expression could be regulated by methylation and androgen signaling pathway. Furthermore, inhibition of CDO1 expression in VCaP prostate cancer cells led to increased cell migration and non-adherent growth. Finally, transcriptomic analysis of these cells with inhibited CDO1 expression demonstrates the complex role of CDO1 and its possible involvement in the mechanisms regulating endoplasmic reticulum stress and protein unfolding. Altogether, these results describe the loss of CDO1 as a marker of aggressiveness in PCa. Furthermore, the loss of CDO1 is thought to be responsible for tumor progression in vitro by acting on multiple signaling pathways.<\/jats:p>","DOI":"10.1038\/s41388-026-03842-5","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T21:56:17Z","timestamp":1781042177000},"page":"2795-2807","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CDO1 is a new biomarker to discriminate aggressive forms of prostate cancer"],"prefix":"10.1038","volume":"45","author":[{"given":"Jeanne","family":"Gaspar Lopes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Markovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile M","family":"Champy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Aubourg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2239-6303","authenticated-orcid":false,"given":"Jacques RR","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Soyeux-Porte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadiatou","family":"Drame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5187-6959","authenticated-orcid":false,"given":"Marine","family":"Louarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4565-0178","authenticated-orcid":false,"given":"Thibaud","family":"Jamet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Huc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"de la Taille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles-Antoine","family":"Dutertre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Destouches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Vacherot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4132-0695","authenticated-orcid":false,"given":"Virginie","family":"Firlej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"3842_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA: A Cancer J Clin"},{"key":"3842_CR2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.gendis.2021.12.023","volume":"10","author":"M Chen","year":"2023","unstructured":"Chen M, Zhu JY, Mu WJ, Guo L. Cysteine dioxygenase type 1 (CDO1): Its functional role in physiological and pathophysiological processes. Genes Dis. 2023;10:877\u201390. https:\/\/doi.org\/10.1016\/j.gendis.2021.12.023.","journal-title":"Genes Dis"},{"key":"3842_CR3","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/0304-3940(90)90814-p","volume":"110","author":"MT Heafield","year":"1990","unstructured":"Heafield MT, Fearn S, Steventon GB, Waring RH, Williams AC, Sturman SG. Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson\u2019s and Alzheimer\u2019s disease. Neurosci Lett. 1990;110:216\u201320. https:\/\/doi.org\/10.1016\/0304-3940(90)90814-p.","journal-title":"Neurosci Lett"},{"key":"3842_CR4","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1089\/ars.2012.5010","volume":"19","author":"HB Roman","year":"2013","unstructured":"Roman HB, Hirschberger LL, Krijt J, Valli A, Ko\u017eich V, Stipanuk MH. The cysteine dioxgenase knockout mouse: altered cysteine metabolism in nonhepatic tissues leads to excess H2S\/HS\u2212 production and evidence of pancreatic and lung toxicity. Antioxid Redox Signal. 2013;19:1321\u201336. https:\/\/doi.org\/10.1089\/ars.2012.5010.","journal-title":"Antioxid Redox Signal"},{"key":"3842_CR5","doi-asserted-by":"publisher","first-page":"E668","DOI":"10.1152\/ajpendo.00151.2011","volume":"301","author":"I Ueki","year":"2011","unstructured":"Ueki I, Roman HB, Valli A, Fieselmann K, Lam J, Peters R, et al. Knockout of the murine cysteine dioxygenase gene results in severe impairment in ability to synthesize taurine and an increased catabolism of cysteine to hydrogen sulfide. Am J Physiol Endocrinol Metab. 2011;301:E668\u2013684. https:\/\/doi.org\/10.1152\/ajpendo.00151.2011.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3842_CR6","doi-asserted-by":"publisher","first-page":"e44951","DOI":"10.1371\/journal.pone.0044951","volume":"7","author":"M Brait","year":"2012","unstructured":"Brait M, Ling S, Nagpal JK, Chang X, Park HL, Lee J, et al. Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers. PLoS One. 2012;7:e44951 https:\/\/doi.org\/10.1371\/journal.pone.0044951.","journal-title":"PLoS One"},{"key":"3842_CR7","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1080\/15592294.2016.1241931","volume":"11","author":"S Meller","year":"2016","unstructured":"Meller S, Zipfel L, Gevensleben H, Dietrich J, Ellinger J, Majores M, et al. CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients. Epigenetics. 2016;11:871\u201380. https:\/\/doi.org\/10.1080\/15592294.2016.1241931.","journal-title":"Epigenetics"},{"key":"3842_CR8","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.neo.2017.10.005","volume":"19","author":"S Hao","year":"2017","unstructured":"Hao S, Yu J, He W, Huang Q, Zhao Y, Liang B, et al. Cysteine dioxygenase 1 mediates erastin-induced ferroptosis in human gastric cancer cells. Neoplasia. 2017;19:1022\u201332. https:\/\/doi.org\/10.1016\/j.neo.2017.10.005.","journal-title":"Neoplasia"},{"key":"3842_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1158\/1078-0432.CCR-12-3751","volume":"19","author":"J Jeschke","year":"2013","unstructured":"Jeschke J, O\u2019Hagan HM, Zhang W, Vatapalli R, Calmon MF, Danilova L, et al. Frequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclines. Clin Cancer Res. 2013;19:12 https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-3751.","journal-title":"Clin Cancer Res"},{"key":"3842_CR10","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s00726-014-1700-8","volume":"46","author":"H Jurkowska","year":"2014","unstructured":"Jurkowska H, Roman HB, Hirschberger LL, Sasakura K, Nagano T, Hanaoka K, et al. Primary hepatocytes from mice lacking cysteine dioxygenase show increased cysteine concentrations and higher rates of metabolism of cysteine to hydrogen sulfide and thiosulfate. Amino Acids. 2014;46:1353\u201365. https:\/\/doi.org\/10.1007\/s00726-014-1700-8.","journal-title":"Amino Acids"},{"key":"3842_CR11","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.3390\/ijms23094491","volume":"23","author":"V Firlej","year":"2022","unstructured":"Firlej V, Soyeux P, Nourieh M, Huet E, Semprez F, Allory Y, et al. Overexpression of nucleolin and associated genes in prostate cancer. Int J Mol Sci. 2022;23:4491 https:\/\/doi.org\/10.3390\/ijms23094491.","journal-title":"Int J Mol Sci"},{"key":"3842_CR12","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M, Repe\u010dka K, McDade F, Kamath A, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38:675\u20138. https:\/\/doi.org\/10.1038\/s41587-020-0546-8.","journal-title":"Nat Biotechnol"},{"key":"3842_CR13","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.canlet.2017.09.010","volume":"410","author":"IY El-Sayed","year":"2017","unstructured":"El-Sayed IY, Daher A, Destouches D, Firlej V, Kostallari E, Maill\u00e9 P, et al. Extracellular vesicles released by mesenchymal-like prostate carcinoma cells modulate EMT state of recipient epithelial-like carcinoma cells through regulation of AR signalling. Cancer Lett. 2017;410:100\u201311. https:\/\/doi.org\/10.1016\/j.canlet.2017.09.010.","journal-title":"Cancer Lett"},{"key":"3842_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.70078","volume":"4","author":"S Chen","year":"2025","unstructured":"Chen S. fastp 1.0: An ultra-fast all-round tool for FASTQ data quality control and preprocessing. Imeta. 2025;4:e70078. https:\/\/doi.org\/10.1002\/imt2.70078.","journal-title":"Imeta"},{"key":"3842_CR15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/bioinformatics\/bty648","volume":"35","author":"B Langmead","year":"2019","unstructured":"Langmead B, Wilks C, Antonescu V, Charles R. Scaling read aligners to hundreds of threads on general-purpose processors. Bioinformatics. 2019;35:421\u201332. https:\/\/doi.org\/10.1093\/bioinformatics\/bty648. Hancock J, \u00e9diteur1 f\u00e9vr.","journal-title":"Bioinformatics"},{"key":"3842_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giab008","volume":"10","author":"P Danecek","year":"2021","unstructured":"Danecek P, Bonfield JK, Liddle J, Marshall J, Ohan V, Pollard MO, et al. Twelve years of SAMtools and BCFtools. Gigascience. 2021;10:giab008. https:\/\/doi.org\/10.1093\/gigascience\/giab008.","journal-title":"Gigascience"},{"key":"3842_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45839-z","volume":"9","author":"HM Amemiya","year":"2019","unstructured":"Amemiya HM, Kundaje A, Boyle AP. The ENCODE blacklist: identification of problematic regions of the genome. Sci Rep. 2019;9:9354. https:\/\/doi.org\/10.1038\/s41598-019-45839-z.","journal-title":"Sci Rep"},{"key":"3842_CR18","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26:841\u20132. https:\/\/doi.org\/10.1093\/bioinformatics\/btq033.","journal-title":"Bioinformatics"},{"key":"3842_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008;9:R137. https:\/\/doi.org\/10.1186\/gb-2008-9-9-r137.","journal-title":"Genome Biol"},{"key":"3842_CR20","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/bioinformatics\/btr064","volume":"27","author":"CE Grant","year":"2011","unstructured":"Grant CE, Bailey TL, Noble WS. FIMO: scanning for occurrences of a given motif. Bioinformatics. 2011;27:1017\u20138. https:\/\/doi.org\/10.1093\/bioinformatics\/btr064.","journal-title":"Bioinformatics"},{"key":"3842_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson JT, Thorvaldsd\u00f3ttir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29:24\u20136. https:\/\/doi.org\/10.1038\/nbt.1754.","journal-title":"Nat Biotechnol"},{"key":"3842_CR22","doi-asserted-by":"publisher","first-page":"8749","DOI":"10.1038\/sj.onc.1205992","volume":"21","author":"T Segawa","year":"2002","unstructured":"Segawa T, Nau ME, Xu LL, Chilukuri RN, Makarem M, Zhang W, et al. Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells. Oncogene. 2002;21:8749\u201358. https:\/\/doi.org\/10.1038\/sj.onc.1205992.","journal-title":"Oncogene"},{"key":"3842_CR23","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00726-011-1128-3","volume":"43","author":"M Higuchi","year":"2012","unstructured":"Higuchi M, Celino FT, Tamai A, Miura C, Miura T. The synthesis and role of taurine in the Japanese eel testis. Amino Acids. 2012;43:773\u201381. https:\/\/doi.org\/10.1007\/s00726-011-1128-3.","journal-title":"Amino Acids"},{"key":"3842_CR24","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41420-022-01277-x","volume":"8","author":"G Ma","year":"2022","unstructured":"Ma G, Zhao Z, Qu Y, Cai F, Liu S, Liang H, et al. Cysteine dioxygenase 1 attenuates the proliferation via inducing oxidative stress and integrated stress response in gastric cancer cells. Cell Death Discov. 2022;8:493 https:\/\/doi.org\/10.1038\/s41420-022-01277-x.","journal-title":"Cell Death Discov"},{"key":"3842_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.14701\/ahbps.2017.21.4.181","volume":"21","author":"Jil Choi","year":"2017","unstructured":"Choi Jil, Cho EH, Kim SB, Kim R, Kwon J, Park M, et al. Promoter methylation of cysteine dioxygenase type 1: gene silencing and tumorigenesis in hepatocellular carcinoma. Ann Hepatobiliary Pancreat Surg. 2017;21:181\u20137. https:\/\/doi.org\/10.14701\/ahbps.2017.21.4.181.","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"3842_CR26","doi-asserted-by":"publisher","first-page":"7449","DOI":"10.1007\/s13277-015-3443-x","volume":"36","author":"J Kwon","year":"2015","unstructured":"Kwon J, Park M, Kim JH, Lee HW, Kang MC, Park JH. Epigenetic regulation of the novel tumor suppressor cysteine dioxygenase 1 in esophageal squamous cell carcinoma. Tumour Biol. 2015;36:7449\u201356. https:\/\/doi.org\/10.1007\/s13277-015-3443-x.","journal-title":"Tumour Biol"},{"key":"3842_CR27","unstructured":"Latil A, Bi\u00e8che I, Ch\u00eane L, Laurendeau I, Berthon P, Cussenot O, et al. Gene expression profiling in clinically localized prostate cancer: a four-gene expression model predicts clinical behavior. Clin Cancer Res. 2003;9:5477\u201385."},{"key":"3842_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0968-6","volume":"31","author":"J Wang","year":"2014","unstructured":"Wang J, Liu D, Zhou W, Wang M, Xia W, Tang Q. Prognostic value of matrix metalloprotease-1\/protease-activated receptor-1 axis in patients with prostate cancer. Med Oncol. 2014;31:968. https:\/\/doi.org\/10.1007\/s12032-014-0968-6.","journal-title":"Med Oncol"},{"key":"3842_CR29","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1016\/j.humpath.2011.02.017","volume":"42","author":"S Minner","year":"2011","unstructured":"Minner S, Kraetzig F, Tachezy M, Kilic E, Graefen M, Wilczak W, et al. Low activated leukocyte cell adhesion molecule expression is associated with advanced tumor stage and early prostate-specific antigen relapse in prostate cancer. Hum Pathol. 2011;42:1946\u201352. https:\/\/doi.org\/10.1016\/j.humpath.2011.02.017.","journal-title":"Hum Pathol"},{"key":"3842_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/pros.10161","volume":"54","author":"G Kristiansen","year":"2003","unstructured":"Kristiansen G, Pilarsky C, Wissmann C, Stephan C, Weissbach L, Loy V, et al. ALCAM\/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions. Prostate. 2003;54:34\u201343. https:\/\/doi.org\/10.1002\/pros.10161.","journal-title":"Prostate"},{"key":"3842_CR31","doi-asserted-by":"publisher","first-page":"6362","DOI":"10.18632\/oncotarget.27279","volume":"10","author":"AJ Sanders","year":"2019","unstructured":"Sanders AJ, Owen S, Morgan LD, Ruge F, Collins RJ, Ye L, et al. Importance of activated leukocyte cell adhesion molecule (ALCAM) in prostate cancer progression and metastatic dissemination. Oncotarget. 2019;10:6362\u201377. https:\/\/doi.org\/10.18632\/oncotarget.27279.","journal-title":"Oncotarget"},{"key":"3842_CR32","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1158\/0008-5472.CAN-13-1296","volume":"74","author":"AG Hansen","year":"2014","unstructured":"Hansen AG, Arnold SA, Jiang M, Palmer TD, Ketova T, Merkel A, et al. ALCAM\/CD166 is a TGF-\u03b2-responsive marker and functional regulator of prostate cancer metastasis to bone. Cancer Res. 2014;74:1404\u201315. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-1296.","journal-title":"Cancer Res"},{"key":"3842_CR33","doi-asserted-by":"publisher","first-page":"e42564","DOI":"10.1371\/journal.pone.0042564","volume":"7","author":"J Jiao","year":"2012","unstructured":"Jiao J, Hindoyan A, Wang S, Tran LM, Goldstein AS, Lawson D, et al. Identification of CD166 as a surface marker for enriching prostate stem\/progenitor and cancer initiating cells. PLOS ONE. 2012;7:e42564 https:\/\/doi.org\/10.1371\/journal.pone.0042564.","journal-title":"PLOS ONE"},{"key":"3842_CR34","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1007\/s12094-021-02650-5","volume":"23","author":"DC Liu","year":"2021","unstructured":"Liu DC, Song LL, Li XZ, Liang Q, Zhang ZG, Han CH. Circular RNA circHIPK3 modulates prostate cancer progression via targeting miR-448\/MTDH signalling. Clin Transl Oncol. 2021;23:2497\u2013506. https:\/\/doi.org\/10.1007\/s12094-021-02650-5.","journal-title":"Clin Transl Oncol"},{"key":"3842_CR35","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.2147\/OTT.S196931","volume":"12","author":"C Cai","year":"2019","unstructured":"Cai C, Zhi Y, Wang K, Zhang P, Ji Z, Xie C, et al. CircHIPK3 overexpression accelerates the proliferation and invasion of prostate cancer cells through regulating miRNA-338-3p. Onco Targets Ther. 2019;12:3363\u201372. https:\/\/doi.org\/10.2147\/OTT.S196931.","journal-title":"Onco Targets Ther"},{"key":"3842_CR36","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.3390\/biomedicines12112640","volume":"12","author":"M Zhou","year":"2024","unstructured":"Zhou M, Tang J, Huang G, Hong L. Prognostic significance and immune landscape of a cuproptosis-related LncRNA signature in ovarian cancer. Biomedicines. 2024;12:2640 https:\/\/doi.org\/10.3390\/biomedicines12112640.","journal-title":"Biomedicines"},{"key":"3842_CR37","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1158\/0008-5472.CAN-23-0285","volume":"83","author":"R Sun","year":"2023","unstructured":"Sun R, Yan B, Li H, Ding D, Wang L, Pang J, et al. Androgen receptor variants confer castration resistance in prostate cancer by counteracting antiandrogen-induced ferroptosis. Cancer Res. 2023;83:3192\u2013204. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-0285.","journal-title":"Cancer Res"},{"key":"3842_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107680","volume":"300","author":"R Wang","year":"2024","unstructured":"Wang R, Yu X, Ye H, Ao M, Xi M, Hou M. LncRNA FAM83H-AS1 inhibits ferroptosis of endometrial cancer by promoting DNMT1-mediated CDO1 promoter hypermethylation. J Biol Chem. 2024;300:107680. https:\/\/doi.org\/10.1016\/j.jbc.2024.107680.","journal-title":"J Biol Chem"},{"key":"3842_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.freeradbiomed.2024.04.222","volume":"219","author":"J Zhang","year":"2024","unstructured":"Zhang J, Yimamu M, Cheng Z, Ji J, Wu L, Feng J, et al. TRIM47-CDO1 axis dictates hepatocellular carcinoma progression by modulating ferroptotic cell death through the ubiquitin\u2012proteasome system. Free Radic Biol Med. 2024;219:31\u201348. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.04.222.","journal-title":"Free Radic Biol Med"},{"key":"3842_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1423","volume":"13","author":"J Yang","year":"2023","unstructured":"Yang J, Sun L, Liu XY, Huang C, Peng J, Zeng X, et al. Targeted demethylation of the CDO1 promoter based on CRISPR system inhibits the malignant potential of breast cancer cells. Clin Transl Med. 2023;13:e1423. https:\/\/doi.org\/10.1002\/ctm2.1423.","journal-title":"Clin Transl Med"},{"key":"3842_CR41","doi-asserted-by":"publisher","first-page":"8498","DOI":"10.18632\/aging.204357","volume":"14","author":"SC Ku","year":"2022","unstructured":"Ku SC, Liu HL, Su CY, Yeh IJ, Yen MC, Anuraga G, et al. Comprehensive analysis of prognostic significance of cadherin (CDH) gene family in breast cancer. Aging (Albany NY). 2022;14:8498\u2013567. https:\/\/doi.org\/10.18632\/aging.204357.","journal-title":"Aging (Albany NY)"},{"key":"3842_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.humpath.2016.10.013","volume":"61","author":"S Figiel","year":"2017","unstructured":"Figiel S, Vasseur C, Bruyere F, Rozet F, Maheo K, Fromont G. Clinical significance of epithelial-mesenchymal transition markers in prostate cancer. Hum Pathol. 2017;61:26\u201332. https:\/\/doi.org\/10.1016\/j.humpath.2016.10.013.","journal-title":"Hum Pathol"},{"key":"3842_CR43","doi-asserted-by":"publisher","first-page":"54051","DOI":"10.18632\/oncotarget.9912","volume":"7","author":"M Storm","year":"2016","unstructured":"Storm M, Sheng X, Arnoldussen YJ, Saatcioglu F. Prostate cancer and the unfolded protein response. Oncotarget. 2016;7:54051\u201366. https:\/\/doi.org\/10.18632\/oncotarget.9912.","journal-title":"Oncotarget"},{"key":"3842_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/ccs3.12054","volume":"18","author":"N Farahani","year":"2024","unstructured":"Farahani N, Alimohammadi M, Raei M, Nabavi N, Aref AR, Hushmandi K, et al. Exploring the dual role of endoplasmic reticulum stress in urological cancers: Implications for tumor progression and cell death interactions. J Cell Commun Signal. 2024;18:e12054. https:\/\/doi.org\/10.1002\/ccs3.12054.","journal-title":"J Cell Commun Signal"},{"key":"3842_CR45","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41585-022-00649-3","volume":"19","author":"CM de la Calle","year":"2022","unstructured":"de la Calle CM, Shee K, Yang H, Lonergan PE, Nguyen HG. The endoplasmic reticulum stress response in prostate cancer. Nat Rev Urol. 2022;19:708\u201326. https:\/\/doi.org\/10.1038\/s41585-022-00649-3.","journal-title":"Nat Rev Urol"},{"key":"3842_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1090277","volume":"14","author":"S Cen","year":"2023","unstructured":"Cen S, Jiang D, Lv D, Xu R, Hou J, Yang Z, et al. Comprehensive analysis of the biological functions of endoplasmic reticulum stress in prostate cancer. Front Endocrinol (Lausanne). 2023;14:1090277. https:\/\/doi.org\/10.3389\/fendo.2023.1090277.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3842_CR47","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1074\/jbc.M310206200","volume":"279","author":"PV Nantermet","year":"2004","unstructured":"Nantermet PV, Xu J, Yu Y, Hodor P, Holder D, Adamski S, et al. Identification of genetic pathways activated by the androgen receptor during the induction of proliferation in the ventral prostate gland. J Biol Chem. 2004;279:1310\u201322. https:\/\/doi.org\/10.1074\/jbc.M310206200.","journal-title":"J Biol Chem"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03842-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03842-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03842-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T22:05:32Z","timestamp":1783375532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03842-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":47,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2026,7,28]]}},"alternative-id":["3842"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03842-5","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"29 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of CPP Ile-de-France V (No.ID-RCB:2016-A00789-42 approved on 6 September 2016) for studies involving humans.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent statement"}},{"value":"During the preparation of this work the authors used DeepL in order to refine language, grammar, and syntax in the preparation of this manuscript. After using this tool\/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the published article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"AI statement"}}]}}